NCT01390779

Brief Summary

The objectives of this study are to assess the safety and effectiveness of the SENSIMED Triggerfish® (TF) device in continuous recording of relative fluctuation in intraocular pressure (IOP). Safety will be assessed by recording of AEs during the 24 hours of continuous TF recording. TF efficacy will be evaluated by demonstrating TF ability to detect:

  1. 1.The known phenomenon of increase in IOP when moving from waking state to going to bed, as reflected in pneumotonometer measurements
  2. 2.Ocular Pulse frequency relative to direct measurement of Heart Rate (HR).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 11, 2011

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

January 20, 2014

Completed
Last Updated

January 20, 2014

Status Verified

December 1, 2013

Enrollment Period

10 months

First QC Date

July 7, 2011

Results QC Date

June 4, 2013

Last Update Submit

December 3, 2013

Conditions

Outcome Measures

Primary Outcomes (2)

  • SENSIMED Triggerfish Efficacy

    Investigate the device's capacity to detect changes in IOP from wake to sleep, defined as a significantly positive slope on the SENSIMED Triggerfish recording (obtained on one eye in each subject), based on the established phenomenon that IOP increases from waking to sleep hours. The IOP from wake to sleep was measured in the eye contralateral to that of SENSIMED Triggerfish using pneumatonomtery. Subjects were included in the primary analysis if a difference in IOP of at least 3 mmHg was detected from wake to sleep. One subject was excluded from the analysis due to the absence of a 3-mmHg difference in IOP from wake to sleep. Two subjects were excluded since they had less than 80% of expected SENSIMED Triggerfish data. One subject was excluded from the analysis due to an invalid SENSIMED Triggerfish recording.

    from 1 hour before sleep to 1 hour after sleep

  • SENSIMED Triggerfish Efficacy

    Device's ability to detect ocular pulse frequency concurrent to heart rate, defined as the number of SENSIMED Triggerfish recording intervals showing oscillation at a frequency matching that of heart rate +/- 15%. In absence of eye blinks during sleep, an oscillating pattern is recorded. The frequency of oscillation was determined by independent reviewers for selected SENSIMED Triggerfish 30-second recording intervals for which simultaneous or close to simultaneous heart rate data was recorded. Intervals for which the oscillation frequency on SENSIMED Triggerfish pattern matched heart rate +/- 15% (tolerance due to noise caused by eye and lid movements) were considered accurate. The percentage of accurate intervals was calculated and expected to be at least 75%.

    in selected 30-second SENSIMED Triggerfish recording intervals during sleep

Study Arms (1)

SENSIMED Triggerfish

EXPERIMENTAL

All subjects enrolled in the trial were housed in a sleep laboratory for 24 hours, during which they underwent SENSIMED Triggerfish recording on one randomly selected eye.

Device: SENSIMED Triggerfish

Interventions

Contact lens-based device intended to continuously record the timing of relative changes in IOP for up to 24 hours

SENSIMED Triggerfish

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent for the investigation
  • Diagnosis of primary open angle glaucoma (POAG), including normal tension glaucoma, or healthy subjects, including subjects with ocular hypertension for whom no evidence or suspicion of structural or functional glaucomatous damage exists
  • No anti-glaucomatous drug treatment or washed-out for 4 weeks
  • IOP symmetry of +/- 3 mmHg between fellow eyes
  • Age 18-80 years
  • Not more than 4 diopters spherical equivalent on both eyes
  • Not more than 2 diopters cylinder equivalent on both eyes

You may not qualify if:

  • Patients who have had ocular surgery within the last 3 months.
  • Corneal or conjunctival abnormality hindering contact lens adaptation
  • Wear of full frame metallic glasses during SENSIMED Triggerfish® monitoring
  • Severe dry eye
  • Secondary forms of open angle glaucoma (OAG)
  • Allergy to corneal anesthetic
  • Patients with contraindications for silicone contact lens wear
  • Patients not able to understand the character and individual consequences of the investigation
  • Simultaneous participation in other clinical research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSD

San Diego, California, 92093-0946, United States

Location

Related Publications (1)

  • Mansouri K, Weinreb RN, Liu JH. Efficacy of a contact lens sensor for monitoring 24-h intraocular pressure related patterns. PLoS One. 2015 May 5;10(5):e0125530. doi: 10.1371/journal.pone.0125530. eCollection 2015.

MeSH Terms

Conditions

Glaucoma, Open-Angle

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Results Point of Contact

Title
Mona Moshtaghi
Organization
UCSD

Study Officials

  • John HK Liu, PhD

    UCSD

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2011

First Posted

July 11, 2011

Study Start

July 1, 2011

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

January 20, 2014

Results First Posted

January 20, 2014

Record last verified: 2013-12

Locations